[The course of diffuse hyperthyroidism in Basedow disease].
An investigation of a large group of patients with Graves' disease demonstrates that this autoimmune disorder of the thyroid is a chronic process with an often protracted course and therefore requires virtually life-long management. Drug therapy (with thionamides) is associated with a high rate of relapse of 60-70%-reliable criteria for the cessation of the autoimmune process are not available. Surgical therapy may also fail to provide lasting control of hyperthyroidism.
Zentrum der Inneren Medizin, Universität Frankfurt/Main.
E
E
Schifferdecker
D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006111:Graves Disease / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013967:Thyroiditis, Autoimmune / Q000188:drug therapy*; D014284:Triiodothyronine / Q000097:blood
D013956:Antithyroid Agents; D014284:Triiodothyronine
Verlauf der diffusen Hyperthyreose des Morbus Basedow.